Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Xeris Biopharma Holdings missed estimated earnings by 75.0%, reporting an EPS of $-0.42 versus an estimate of $-0.24.

Revenue was up $14.34 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.02 which was followed by a 9.47% increase in the share price the next day.

Here's a look at Xeris Biopharma Holdings's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.